These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26411363)
1. Conjugation of SUMO to p85 leads to a novel mechanism of PI3K regulation. de la Cruz-Herrera CF; Baz-Martínez M; Lang V; El Motiam A; Barbazán J; Couceiro R; Abal M; Vidal A; Esteban M; Muñoz-Fontela C; Nieto A; Rodríguez MS; Collado M; Rivas C Oncogene; 2016 Jun; 35(22):2873-80. PubMed ID: 26411363 [TBL] [Abstract][Full Text] [Related]
2. SUMOylation modulates the stability and function of PI3K-p110β. El Motiam A; de la Cruz-Herrera CF; Vidal S; Seoane R; Baz-Martínez M; Bouzaher YH; Lecona E; Esteban M; Rodríguez MS; Vidal A; Collado M; Rivas C Cell Mol Life Sci; 2021 Apr; 78(8):4053-4065. PubMed ID: 33834259 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of PI3K binding to activators by serine phosphorylation of PI3K regulatory subunit p85alpha Src homology-2 domains. Lee JY; Chiu YH; Asara J; Cantley LC Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14157-62. PubMed ID: 21825134 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases. Dornan GL; Burke JE Front Immunol; 2018; 9():575. PubMed ID: 29616047 [TBL] [Abstract][Full Text] [Related]
5. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Hofmann BT; Jücker M Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity. Li Y; Anderson DH; Liu Q; Zhou Y J Biol Chem; 2008 Aug; 283(34):23397-409. PubMed ID: 18534979 [TBL] [Abstract][Full Text] [Related]
7. Quantitation of class IA PI3Ks in mice reveals p110-free-p85s and isoform-selective subunit associations and recruitment to receptors. Tsolakos N; Durrant TN; Chessa T; Suire SM; Oxley D; Kulkarni S; Downward J; Perisic O; Williams RL; Stephens L; Hawkins PT Proc Natl Acad Sci U S A; 2018 Nov; 115(48):12176-12181. PubMed ID: 30442661 [TBL] [Abstract][Full Text] [Related]
8. Insights into the pathological mechanisms of p85α mutations using a yeast-based phosphatidylinositol 3-kinase model. Oliver MD; Fernández-Acero T; Luna S; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143957 [TBL] [Abstract][Full Text] [Related]
9. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. Jimenez C; Hernandez C; Pimentel B; Carrera AC J Biol Chem; 2002 Nov; 277(44):41556-62. PubMed ID: 12196526 [TBL] [Abstract][Full Text] [Related]
10. Defining How Oncogenic and Developmental Mutations of PIK3R1 Alter the Regulation of Class IA Phosphoinositide 3-Kinases. Dornan GL; Stariha JTB; Rathinaswamy MK; Powell CJ; Boulanger MJ; Burke JE Structure; 2020 Feb; 28(2):145-156.e5. PubMed ID: 31831213 [TBL] [Abstract][Full Text] [Related]
11. A p85 isoform switch enhances PI3K activation on endosomes by a MAP4- and PI3P-dependent mechanism. Thapa N; Chen M; Cryns VL; Anderson R Cell Rep; 2024 May; 43(5):114119. PubMed ID: 38630589 [TBL] [Abstract][Full Text] [Related]
13. Divergent roles of the regulatory subunits of class IA PI3K. Kim CW; Lee JM; Park SW Front Endocrinol (Lausanne); 2023; 14():1152579. PubMed ID: 38317714 [TBL] [Abstract][Full Text] [Related]
14. Overview of the regulation of the class IA PI3K/AKT pathway by SUMO. Vidal S; Bouzaher YH; El Motiam A; Seoane R; Rivas C Semin Cell Dev Biol; 2022 Dec; 132():51-61. PubMed ID: 34753687 [TBL] [Abstract][Full Text] [Related]
15. BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity. Chiu YH; Lee JY; Cantley LC Mol Cell; 2014 Apr; 54(1):193-202. PubMed ID: 24657164 [TBL] [Abstract][Full Text] [Related]
16. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792 [TBL] [Abstract][Full Text] [Related]
17. Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking. Mellor P; Furber LA; Nyarko JN; Anderson DH Biochem J; 2012 Jan; 441(1):23-37. PubMed ID: 22168437 [TBL] [Abstract][Full Text] [Related]
18. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? Geering B; Cutillas PR; Vanhaesebroeck B Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237 [TBL] [Abstract][Full Text] [Related]
19. Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. Hale BG; Batty IH; Downes CP; Randall RE J Biol Chem; 2008 Jan; 283(3):1372-1380. PubMed ID: 18029356 [TBL] [Abstract][Full Text] [Related]
20. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase. Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]